Afuco™ Anti-CD79B ADCC Therapeutic Antibody (Polatuzumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human CD79B.
Supplier Creative Biolabs
Product # AFC-TAB-897
Pricing Inquiry
Host Human
Target CD79B
Species Reactivity Human
Type ADCC enhanced antibody
Applications Neut, ELISA, IF, IP, FuncS, FC
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback